There were no differences in mental health outcomes between montelukast and long-acting beta-agonists. Psychiatric events rose over time, likely due to increased screening, diagnoses and awareness.

We are now in the final stages of our review. We continue to closely monitor reports of suspected neuropsychiatric adverse ...

Montelukast is a prescription drug also known by its brand ... the risk for the drug given current international ...

Nasal steroids provided the most significant benefit, especially when compared to montelukast. Nasal antihistamines also ...